 SEATTLE, March 23, 2022 GLOBE NEWSWIRE -- Atossa Therapeutics, Inc. Nasdaq: ATOS, a clinical-stage biopharmaceutical company seeking to develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, today announces that management will participate at the Maxim Group 2022 Virtual Growth Conference, which is being held March 28-30, 2022. 